Back to search

Aristotle University Of Thessaloniki (AUTH)

Συγκριτική μελέτη της δράσης της ιρμπεσαρτάνης και της νεμπιβολόλης στην περιπατιτική αρτηριακή πίεση ασθενών με υπέρταση κατά την διάρκεια της αιμοκάθαρσης

Abstract

dc:description

Approximately 8-15% of end stage renal disease patients show increase in blood pressure during dialysis. This phenomenon is called intradialytic hypertension and is associated with increased morbidity and mortality from cardiovascular events. There are several definitions of the phenomenon in the literature, but what seems to be prevalent is the intradialytic increase in SBP ≥10 mmHg. Increased sympathetic nervous system activity, increased production of renin, increased arterial stiffness, endothelial dysfunction, fluid and sodium overload and removal of antihypertensive drugs during hemodialysis seems to be involved in the pathogenesis of the phenomenon. This study involved 38 patients with intradialytic hypertension. After baseline evaluation, patients were randomly assigned to nebivolol 5 mg and subsequently irbesartan 150 mg, or vice versa. Nineteen patients received a single drug-dose 1 h before hemodialysis and 19 received the drug for a week before evaluation. A 2-week wash-out period took place between the two drugs. Patients receiving a single dose of either drug had lower postdialysis BP. The 24-h BP presented a trend towards reduction, but was significant only for 24-h DBP in the nebivolol arm. Patients on weekly administration of either drug had lower postdialysis BP, and in the nebivolol arm lower intradialytic and 24hours BP. No significant differences were observed in comparisons between the two drugs. Patients receiving a single dose of nebivolol had lower postdialysis central SBP and 24hours central SBP presented a trend towards reduction. No significant differences were observed in comparisons, between baseline evaluation and nebivolol in PWV. No significant differences were observed in patients receiving a single dose of irbesartan in comparison to baseline, with the exception of postdialysis central DBP. Patients on weekly administration of nebivolol had significantly and on irbesartan non significantly lower 24hours central SBP and DBP. Both drugs reduced significantly postdialysis central SBP, DBP and PWV compared to baseline. In addition, for the whole population of the study during the 24hours period, SBP variability indexes (SD, wSD, CV, ARV) were marginally lower after nebivolol but not after irbesartan. There were no differences between the two drugs. In contrast, DBP variability decreased in the nebivolol and increased in the irbesartan arm, resulting in significant differences between the two drugs. Finally, the comparison of aortic and brachial variability indexes between patients with and without intradialytic hypertension revealed that in 48hours and 44hours period, but also in daily and nocturnal periods of the first 24hours, SBP and DBP were significantly higher in patients with intradialytic hypertension than controls. All brachial and aortic SBP variability indexes for the 44h and 48h intervals did not differ significantly in both groups. Both 48h DBP-CV and DBP-ARV were significantly lower in cases than in controls. During both the first and the second 24hours period daily SBP variability indexes were similar in both groups, but brachial and aortic DBP-CV were significantly lower in patients with intradialytic hypertension. During the nightime of the second 24hours period, SBP-CV and SBP-ARV were signifficantly lower in patients. There were no significant differences in dipping profile between the two groups.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bikos, Athanasios
  • Μπίκος, Αθανάσιος

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45329

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bikos, Athanasios; Μπίκος, Αθανάσιος. Συγκριτική μελέτη της δράσης της ιρμπεσαρτάνης και της νεμπιβολόλης στην περιπατιτική αρτηριακή πίεση ασθενών με υπέρταση κατά την διάρκεια της αιμοκάθαρσης. Aristotle University Of Thessaloniki (AUTH), 2019. http://hdl.handle.net/10442/hedi/45329